2022-11-10 | Sage Therapeutics, Inc. SAGE | President and CEO | 14,500 0.024% | $34.48 | $500,022 | +19.18% | ||
2021-08-05 | Sage Therapeutics, Inc. SAGE | President and CEO | 23,640 0.0401% | $43.15 | $1.02M | -10.58% | ||
2021-06-16 | Sage Therapeutics, Inc. SAGE | President and CEO | 8,800 0.0154% | $56.32 | $495,627 | -24.87% | ||
2020-09-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 44,530 0.0384% | $123.23 | $5.49M | +16.3% | |
2020-07-07 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 22,265 0.0192% | $159.99 | $3.56M | -12.51% | |
2020-05-06 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 22,265 0.02% | $149.99 | $3.34M | -4.35% | |
2019-10-22 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 58,913 0.0532% | $89.99 | $5.3M | +45.29% | |
2018-03-14 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 76,920 0.0776% | $143.10 | $11.01M | -34.38% | |
2017-10-02 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 170,632 0.1062% | $73.17 | $12.49M | -5.49% | |
2017-09-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 153,630 0.147% | $100.00 | $15.36M | +2.82% | |
2016-12-01 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President | 63,650 0.0767% | $42.99 | $2.74M | +73.81% | |
2015-05-26 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 134,758 0.0863% | $69.06 | $9.31M | -30.86% | |
2015-04-02 | Karyopharm Therapeutics Inc. KPTI | director | 6,000 0.0167% | $29.31 | $175,877 | -51.65% | ||
2014-12-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 22,400 0.0299% | $100.00 | $2.24M | +4.47% | |
2014-11-17 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 66,400 0.09% | $89.63 | $5.95M | +17.69% | |
2014-11-11 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 22,200 0.0162% | $53.39 | $1.19M | +6.35% | |
2013-05-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 22,822 0.0248% | $19.95 | $455,339 | +93.71% | |
2013-03-14 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President & COO | 48,116 0.0422% | $12.97 | $624,305 | +115.11% | |
2013-03-08 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 48,000 0.0419% | $12.69 | $609,070 | +115.83% | |
2012-02-21 | Alnylam Pharmaceuticals, Inc. ALNY | President and COO | 3,720 0.0072% | $10.75 | $39,990 | +41.4% |